EyeGate Pharma Announces Positive Top-line Data from First-in-Human Pilot Trial of Ocular Bandage Gel in Corneal Epithelial Defects Pharmaceutical Investing
DelMar Pharmaceuticals, Inc. – "Optimism and Opportunity as we Initiate Clinical Trials for MGMT-unmethylated GBM Patients at MD Anderson" Life Science Investing
Immune Therapeutics Announces Special Investor Conference Call to Discuss 2017 Outlook Biotech Investing
Emergent BioSolutions Receives Approval for Large-Scale Manufacturing of BioThrax Pharmaceutical Investing
Abiomed Announces Q3 FY 2017 Revenue of $114.7 Million, Up 34% Over Prior Year Medical Device Investing
Medtronic Receives IDE Approval to Initiate Study for End-Stage Renal Disease Pharmaceutical Investing
BriaCell and BriaPro to Present Preclinical Anti-Cancer Activity and Immunotherapy Findings at SITC 2026Â
